Medical Condition News

RSS

MAP Pharmaceuticals reports results from PD trial that compares effects of LEVADEX, IV DHE

MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.

8 Sep 2010

Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients

Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.

8 Sep 2010

Positive results from YM BioSciences' CYT997 Phase I study for vascular disruption in tumors

YM BioSciences Inc., today announced the publication of Phase I results demonstrating that CYT997, a novel vascular disrupting agent (VDA), was well tolerated at doses that were associated with pharmacodynamic evidence of vascular disruption in tumors. The article entitled "Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent," was published in the premier cancer journal, the British Journal of Cancer.

8 Sep 2010

Perrigo receives FDA approval to manufacture, market Imiquimod Cream, 5%

Perrigo Company announced it received FDA approval from the U.S. Food and Drug Administration to manufacture and market Imiquimod Cream, 5%. Perrigo will vertically integrate this product with their own API.

8 Sep 2010

Mary Ann Liebert launches Childhood Obesity journal to promote clinical advances

Publisher Mary Ann Liebert announced the launch of Childhood Obesity to provide physicians, nurses, dietitians, diabetes educators, nutritionists, psychologists, educators and school nurses, community organizers, and policymakers with effective prevention and treatment strategies that promote environmental and policy changes, patient education and motivation tools, and clinical advances in the field.

8 Sep 2010

Virginia Commonwealth University experts available to discuss childhood obesity

Virginia Commonwealth University has experts available in pediatric obesity, psychology, medicine and fashion to discuss a variety of topics including healthy eating, physical activity, lifestyle programs and strategies, trends and causes related to childhood obesity during the month of September.

8 Sep 2010

PLX4032 trial shows high degree of selectivity to achieve tumor shrinkage

Plexxikon today announced publication of key data in this week's edition of Nature demonstrating that the high degree of selectivity of PLX4032 (RG7204) enables substantial RAF/MEK/ERK pathway inhibition, which may be necessary to achieve significant tumor shrinkage and clinical response in patients with BRAF mutant melanoma.

8 Sep 2010

STAAR Surgical's Visian Implantable Collamer Lens featured prominently at 2010 ESCRS Congress

STAAR Surgical Company, the leading worldwide developer, manufacturer and marketer of phakic intraocular lenses, today announced that the Visian Implantable Collamer® Lens (ICL) was featured prominently in more than 40 presentations by leading ophthalmologists at meetings prior to and during the 2010 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) held in Paris, France from September 4 through 8, 2010.

8 Sep 2010

ImmuneRegen's Homspera with Scancell's ImmunoBody technology improves immune response for cancer

ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. today announced that treatment with its lead compound, Homspera, in combination with a DNA vaccine utilizing Scancell's ImmunoBody technology significantly improved the immune response of the vaccine in an animal model.

8 Sep 2010

Researchers to study suicide prevention program in high schools

With students returning to classes, University of Rochester Medical Center researchers are beginning a large, long-term study of the effectiveness of a unique suicide prevention program in high schools across New York and North Dakota.

8 Sep 2010

Vitamin D may improve asthma: Report

Supplement your asthma action plan with Vitamin D and you may experience improved asthma control according to an article published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

8 Sep 2010

Reports on smoking rates among Americans reveal dramatic progress in fight against tobacco

Two new reports released today by the Centers for Disease Control and Prevention show that while the United States has made dramatic progress in the fight against tobacco, too many Americans still smoke and too many non-smokers including more than half of all young children are still exposed to secondhand smoke.

8 Sep 2010

Researchers find blebbistatin chemically inhibits NMII, enhances survival of stem cells

Human pluripotent stem (hPS) cells can generate any given cell type in the adult human body, which is why they are of interest to stem cell scientists working on finding therapies for spinal cord injuries, Parkinson's disease, burns, heart disease, diabetes, arthritis, and other ailments.

8 Sep 2010

ECNP honors Kaj Blennow with 2010 Neuropsychopharmacology Award

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Kaj Blennow as the recipient of the 2010 ECNP Neuropsychopharmacology Award in recognition of his original and influential contributions to Alzheimer's disease research. The ECNP Neuropsychopharmacology Award is presented annually and recognises distinguished research in neuropsychopharmacology and closely related disciplines. The award is accompanied by a prize of - 20,000.

8 Sep 2010

Oxygen Biotherapeutics offers traumatic brain injury trials for Israeli soldiers

Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing oxygen-rich intravenous and topical products, today announced that Israeli soldiers who suffer severe traumatic brain injury (TBI) can be enrolled in the company's Phase II-b STOP-TBI trials at clinical sites in Israel.

8 Sep 2010

$FRAX model helps to evaluate fracture risk$

FRAX model helps to evaluate fracture risk

The WHO Fracture Risk Assessment Tool (FRAX-) is being used increasingly by physicians to help evaluate fracture risk and identify those people who are most in need of osteoporosis treatment. To date, FRAX- models are available for 26 countries, with more currently in planning.

8 Sep 2010

KRN cell transfer model provides novel opportunity for rheumatoid arthritis research

Current research provides a novel model for rheumatoid arthritis research. The related report by LaBranche et al, "Characterization of the KRN cell transfer model of rheumatoid arthritis, a chronic yet synchronized version of the K/BxN mouse," appears in the September 2010 issue of The American Journal of Pathology.

8 Sep 2010

Gemcitabine does not improve survival compared with fluorouracil plus folinic acid in resected pancreatic cancer

Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA.

8 Sep 2010

TransOral Robotic Surgery removes head and neck cancer tumors, while preserving speech

An incisionless robotic surgical procedure is offering patients a new option to remove certain head and neck cancer tumors without visible scarring, while preserving speech and the ability to eat.

8 Sep 2010

Study suggests better quality primary care improves health

Financial incentives in primary care cut heart disease deaths and hospital admissions, particularly among people from deprived areas, finds research published online in the Journal of Epidemiology and Community Health.

8 Sep 2010

Medical Condition News

MAP Pharmaceuticals reports results from PD trial that compares effects of LEVADEX, IV DHE

Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients

Positive results from YM BioSciences' CYT997 Phase I study for vascular disruption in tumors

Perrigo receives FDA approval to manufacture, market Imiquimod Cream, 5%

Mary Ann Liebert launches Childhood Obesity journal to promote clinical advances

Virginia Commonwealth University experts available to discuss childhood obesity

PLX4032 trial shows high degree of selectivity to achieve tumor shrinkage

STAAR Surgical's Visian Implantable Collamer Lens featured prominently at 2010 ESCRS Congress

ImmuneRegen's Homspera with Scancell's ImmunoBody technology improves immune response for cancer

Researchers to study suicide prevention program in high schools

Vitamin D may improve asthma: Report

Reports on smoking rates among Americans reveal dramatic progress in fight against tobacco

Researchers find blebbistatin chemically inhibits NMII, enhances survival of stem cells

ECNP honors Kaj Blennow with 2010 Neuropsychopharmacology Award

Oxygen Biotherapeutics offers traumatic brain injury trials for Israeli soldiers

FRAX model helps to evaluate fracture risk

KRN cell transfer model provides novel opportunity for rheumatoid arthritis research

Gemcitabine does not improve survival compared with fluorouracil plus folinic acid in resected pancreatic cancer

TransOral Robotic Surgery removes head and neck cancer tumors, while preserving speech

Study suggests better quality primary care improves health

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News